|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Febrile Neutropenia | |||||
| Suspicion of Endocarditis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Endocarditis | |||||
| Neutropenia | |||||
| Sepsis | |||||
| 3 | More general conditions related to this trial | ||||
| Agranulocytosis | |||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Hematologic Diseases | |||||
| Infection | |||||
| Inflammation | |||||
| Leukocyte Disorders | |||||
| Leukopenia | |||||
| Pathologic Processes | |||||
| Systemic Inflammatory Response Syndrome | |||||
| 4 | Sponsors listed in this trial | ||||
| Assistance Publique - Hôpitaux de Paris | |||||
| Hoffmann-La Roche | |||||